Clene

CLNN · NASDAQ

$3.73+$0.44 (+13.37%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $3.29

Latest news

NewsOct 20, 4:43 AM ETAvi Kapoor
Why 3M Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Press releaseOct 19, 8:00 AM ETGlobe Newswire
Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS
Press releaseSep 21, 8:30 AM ETGlobe Newswire
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
Press releaseSep 15, 9:00 AM ETGlobe Newswire
Clene Announces $4 Million Registered Direct Offering
Press releaseSep 8, 8:30 AM ETGlobe Newswire
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
Press releaseAug 14, 8:30 AM ETGlobe Newswire
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
Press releaseAug 10, 8:00 AM ETGlobe Newswire
Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
Press releaseJun 22, 8:30 AM ETGlobe Newswire
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
Press releaseMay 14, 8:00 AM ETGlobe Newswire
Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights
Press releaseMay 5, 8:45 AM ETGlobe Newswire
Clene Announces $7 Million Underwritten Offering of Common Stock
NewsMay 4, 11:22 AM ETVandana Singh
Clene Stock Jumps After FDA Opens Door To Accelerated Approval For ALS Drug
NewsMay 4, 11:15 AM ETVandana Singh
Mirum Pharmaceuticals Rally Reflects Confidence In Late-Stage Liver Disease Assets
Press releaseMay 4, 8:00 AM ETGlobe Newswire
After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS
NewsNov 14, 7:06 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsOct 31, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsAug 20, 8:08 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsJul 18, 5:06 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
Press releaseJun 9, 9:00 AM ETACCESS Newswire
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025
NewsJun 3, 8:07 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Press releaseFeb 27, 9:15 AM ETACCESS Newswire
Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11
NewsSep 6, 5:41 AM ETAvi Kapoor
Why Argan Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Press releaseAug 8, 8:00 AM ETGlobe Newswire
IBN Announces Latest Episode of The BioMedWire Podcast featuring Rob Etherington, CEO of Clene Inc.
NewsJul 11, 2:35 PM ETAvi Kapoor
Gold Rises Sharply; Methode Electronics Shares Spike Higher
NewsJul 11, 2:02 PM ETAvi Kapoor
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
NewsJul 11, 12:01 PM ETAvi Kapoor
Nasdaq Dips Over 300 Points; PepsiCo Reports Weak Sales
NewsJul 9, 2:38 PM ETAvi Kapoor
S&P 500 Edges Higher; Indivior Shares Plummet
NewsJul 9, 12:59 PM ETAvi Kapoor
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
NewsJul 9, 12:11 PM ETAvi Kapoor
Crude Oil Down 1%; Soligenix Shares Surge

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Why 3M Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS

Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA

Clene Announces $4 Million Registered Direct Offering

A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach

Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights

Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights

Clene Announces $7 Million Underwritten Offering of Common Stock

Clene Stock Jumps After FDA Opens Door To Accelerated Approval For ALS Drug

Mirum Pharmaceuticals Rally Reflects Confidence In Late-Stage Liver Disease Assets

After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11

Why Argan Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

IBN Announces Latest Episode of The BioMedWire Podcast featuring Rob Etherington, CEO of Clene Inc.

Gold Rises Sharply; Methode Electronics Shares Spike Higher

Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Nasdaq Dips Over 300 Points; PepsiCo Reports Weak Sales

S&P 500 Edges Higher; Indivior Shares Plummet

Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Crude Oil Down 1%; Soligenix Shares Surge